Your browser doesn't support javascript.
loading
Efficacy and safety of simoctocog alfa (Nuwiq®) in patients with severe hemophilia A: a review of clinical trial data from the GENA program.
Lissitchkov, Toshko; Klukowska, Anna; Pasi, John; Kessler, Craig M; Klamroth, Robert; Liesner, Raina J; Belyanskaya, Larisa; Walter, Olaf; Knaub, Sigurd; Bichler, Johann; Jansen, Martina; Oldenburg, Johannes.
Afiliação
  • Lissitchkov T; Specialised Hospital for Active Treatment "Joan Pavel", Sofia, Bulgaria.
  • Klukowska A; Department of Pediatrics, Hematology and Oncology, Warsaw Medical University, Poland.
  • Pasi J; The Royal London Hospital Barts and The London School of Medicine and Dentistry, UK.
  • Kessler CM; Hemophilia and Thrombosis Comprehensive Treatment Center and The Division of Coagulation, Georgetown University Medical Center, Washington DC, USA.
  • Klamroth R; Department for Internal Medicine, Vascular Medicine and Haemostaseology, Vivantes Klinikum im Friedrichshain, Berlin, Germany.
  • Liesner RJ; Great Ormond Street Hospital for Children, NHS Trust Haemophilia Centre, London, UK.
  • Belyanskaya L; Octapharma AG, Lachen, Switzerland.
  • Walter O; Octapharma AG, Lachen, Switzerland.
  • Knaub S; Octapharma AG, Lachen, Switzerland.
  • Bichler J; Octapharma AG, Lachen, Switzerland.
  • Jansen M; Octapharma Pharmazeutika Produktionsges mbH, Vienna, Austria.
  • Oldenburg J; Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Sigmund-Freud Strasse 25, 53105 Bonn, Germany.
Ther Adv Hematol ; 10: 2040620719858471, 2019.
Article em En | MEDLINE | ID: mdl-31263528

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Ther Adv Hematol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Bulgária

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Ther Adv Hematol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Bulgária